Hec Cj Pharm
Hec Cj Pharm, officially known as Hec Pharm Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, Hec Cj Pharm is recognised for its commitment to innovation and quality. The company’s unique approach combines advanced technology with rigorous quality control, ensuring that its products meet international standards. With a solid market position, Hec Cj Pharm has achieved notable milestones, including various certifications and partnerships that enhance its reputation in the global market. The company continues to expand its portfolio, contributing significantly to the healthcare sector.
DitchCarbon Score
How does Hec Cj Pharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hec Cj Pharm's score of 17 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hec Cj Pharm's reported carbon emissions
In 2023, Hec Cj Pharm reported total carbon emissions of approximately 68,798,560 kg CO2e, with Scope 1 emissions at about 1,970 kg CO2e and Scope 2 emissions at approximately 68,796,590 kg CO2e. This marks a significant increase from 2022, where emissions were around 62,205,490 kg CO2e. The company has shown a trend of increasing emissions over the years, with total emissions rising from about 13,168,540 kg CO2e in 2017 to the latest figure in 2023. Notably, in 2021, emissions peaked at approximately 63,666,380 kg CO2e, indicating a fluctuating but generally upward trajectory. Despite these figures, Hec Cj Pharm has not disclosed any specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of documented climate pledges or science-based targets suggests a need for enhanced commitment to sustainability practices within the pharmaceutical industry. Overall, while Hec Cj Pharm's emissions data reflects substantial operational activity, the lack of clear reduction strategies highlights an opportunity for the company to align with global climate goals and improve its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 49,760 | 00,000 | 00,000 | 0,000 | 0,000 |
| Scope 2 | 34,606,960 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hec Cj Pharm is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
